I'll tell ya what T.P. - some of those statements in the report with regards to Executive changes are total bollocks! EOS make the following statement;
"In addition, during the quarter, EOS reduced the size of the Executive Management team and reduced costs."
Junk mail! Gilmore, Short and Smith all "left" the company in July and September. Throw Bryant into the mix as having resigned and Glen Tindall "finished" working with the company in August (As I had confirmed on previous threads). They like to make it sound that it was all by design. And yet, you get dunderklumpens who stepped down into other roles, only to have their previous roles re-filled or retitled such as "Acting Vice Presidents x 2". Just the mere fact that the founder is still lurking as a Director and still receiving a remuneration as "Head of Innovation" is laughable.
And then to state that "Management expects to eliminate over 100 roles in EOS"...but in the meantime "EOS is taking steps to appoint Managers" is a comical read in itself!. And yet, when I posted the 'Glassdoor reviews' a particular patriot of EOS slammed my post as pathetic research.
I'm happy to be the resident loudmouth on these threads. Even with cost reduction and an improved revenue stream, EOS will be swimming against the tide for a long, long while yet. And come time to maybe start ramping up production, should it ever occur, I'd hate to see how inflated the input costs will be, especially in relation to pressure in wages/salaries.
Woof, woof. Back to the kennel.
- Forums
- ASX - By Stock
- Ann: Business Activity Statement & Appendix 4C - Sep-22 Qtr
EOS
electro optic systems holdings limited
Add to My Watchlist
2.26%
!
$2.71

I'll tell ya what T.P. - some of those statements in the report...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.71 |
Change
0.060(2.26%) |
Mkt cap ! $522.9M |
Open | High | Low | Value | Volume |
$2.68 | $2.78 | $2.67 | $3.647M | 1.341M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 40141 | $2.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.73 | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 2.700 |
1 | 10000 | 2.680 |
1 | 5000 | 2.670 |
5 | 16825 | 2.650 |
3 | 7303 | 2.630 |
Price($) | Vol. | No. |
---|---|---|
2.740 | 1149 | 1 |
2.750 | 2722 | 2 |
2.780 | 15437 | 4 |
2.790 | 4579 | 2 |
2.800 | 38947 | 11 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
EOS (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online